MetaCore is used for target identification, validation, biomarker discovery and knowledge mining. According to GeneGo, GlaxoSmithKline (GSK) will also use the platform as a repository of all types of experimental data as well as resulting analyses. MetaBase is direct access to the manually curated database of pathways, networks, ontologies, medicinal chemistry and diseases covering human, mouse and rat. MapEditor is a research tool for creating interactive custom maps which amalgamate MetaBase knowledge content with proprietary information and data.
Julie Bryant, GeneGo’s vice president of business development, said: “We have a good working relationship with GSK developing new products such as our pay as you go 1-2-3 Workflow. We will continue to work closely developing new functionality, tools and content for GSK.”